Takahiro Ishitsuka
Ariake, 1358550, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Impact of second-line combination chemotherapy on post-progression survival in metastatic and recurrent pancreatic cancer.
Journal: International journal of clinical oncology
Published: February 05, 2025
Liver Oligometastasis in Biliary Tract Cancer and Impact on Survival Outcomes.
Journal: Journal of gastrointestinal cancer
Published: August 06, 2024
Bone loss over time and risk of osteoporosis in advanced pancreatic cancer.
Journal: Japanese journal of clinical oncology
Published: January 03, 2024
Splenic Hilar Involvement and Sinistral Portal Hypertension in Unresectable Pancreatic Tail Cancer.
Journal: Cancers
Published: November 12, 2023
Safety and Effectiveness of Chemotherapy in Elderly Biliary Tract Cancer Patients.
Journal: Current oncology (Toronto, Ont.)
Published: June 29, 2023
The impact of osteosarcopenia in patients with unresectable or recurrent biliary tract cancer receiving palliative chemotherapy.
Journal: Japanese journal of clinical oncology
Published: June 21, 2023
Outcomes of partially covered self-expandable metal stents with different uncovered lengths in endoscopic ultrasound-guided hepaticogastrostomy: a Japanese retrospective study.
Journal: Clinical endoscopy
Published: May 24, 2023
Late-onset hemobilia due to pseudoaneurysm rupture after endoscopic ultrasound-guided hepaticogastrostomy.
Journal: Clinical journal of gastroenterology
Published: April 25, 2023
Outcomes of Intraductal Placement of Covered Metal Stents for Unresectable Distal Malignant Biliary Obstruction.
Journal: Journal of clinical medicine
Published: January 21, 2023
Prognostic impact of osteosarcopenia in patients with advanced pancreatic cancer receiving gemcitabine plus nab-paclitaxel.
Journal: Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]
Published: December 26, 2022
Treatment Outcomes and Prognostic Factors of Gemcitabine Plus Nab-Paclitaxel as Second-Line Chemotherapy after Modified FOLFIRINOX in Unresectable Pancreatic Cancer.
Journal: Cancers
Published: December 05, 2022
Last Updated: 09/26/2026